Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     

INTUITIVE SURGICAL, INC.

(ISRG)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Insider Sell: Intuitive Surgical

07/29/2022 | 07:10am EDT


© MT Newswires 2022
All news about INTUITIVE SURGICAL, INC.
10/04Vergent Bioscience, Inc. announced that it has received $21.542628 million in funding f..
CI
10/03Japan regulatory agency clears Intuitive's single-port robotic surgical system
AQ
09/30Intuitive Surgical Says Japan Regulator Clears da Vinci SP Robotic Surgical System
MT
09/30Japan regulatory agency clears Intuitive's single-port robotic surgical system
GL
09/30Japan regulatory agency clears Intuitive's single-port robotic surgical system
AQ
09/30Japan Regulatory Agency Clears Intuitive Surgical, Inc. Single-Port Robotic Surgical Sy..
CI
09/27Optellum, AI Lung Cancer Diagnosis Innovator, Secures $14M Series A Funding to Accelera..
PR
09/22Sector Update: Health Care Stocks Gain Thursday Afternoon
MT
09/22Sector Update: Health Care Stocks Rising in Defensive Thursday Trading
MT
09/22Luna Innovations Says $14.2 Million Signed With Intuitive Surgical for Delivery of Phot..
MT
More news
Analyst Recommendations on INTUITIVE SURGICAL, INC.
More recommendations
Financials (USD)
Sales 2022 6 212 M - -
Net income 2022 1 403 M - -
Net cash 2022 1 710 M - -
P/E ratio 2022 51,8x
Yield 2022 -
Capitalization 70 601 M 70 601 M -
EV / Sales 2022 11,1x
EV / Sales 2023 9,68x
Nbr of Employees 9 793
Free-Float 99,5%
Chart INTUITIVE SURGICAL, INC.
Duration : Period :
Intuitive Surgical, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends INTUITIVE SURGICAL, INC.
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 21
Last Close Price 197,70 $
Average target price 253,29 $
Spread / Average Target 28,1%
EPS Revisions
Managers and Directors
Gary S. Guthart Chief Executive Officer & Director
Jamie E. Samath Chief Financial Officer & Senior Vice President
Craig H. Barratt Chairman
Myriam J. Curet Chief Medical Officer & Executive Vice President
Kara Andersen Reiter Assistant General Counsel
Sector and Competitors